Table 2.
Number and percentage of patients reaching target HbA1c levels and time in hypoglycemia
| Time point and variable | n (%) | 95% CI for % |
|---|---|---|
| Baseline | ||
| HbA1c <7.5% and <1.0% time in hypoglycemia (<3.0 mmol/L) | 2 (15.4) | 1.9–45.5 |
| HbA1c <7.5% and <4.0% time in hypoglycemia (<3.9 mmol/L) | 3 (23.1) | 5.0–53.8 |
| HbA1c <7.0% and <1.0% time in hypoglycemia (<3.0 mmol/L) | 0 (0.0) | |
| HbA1c <7.0% and <4.0% time in hypoglycemia (<3.9 mmol/L) | 0 (0.0) | |
| End of conventional treatment | ||
| HbA1c <7.5% and <1.0% time in hypoglycemia (<3.0 mmol/L) | 5 (21.7) | 7.5–43.7 |
| HbA1c <7.5% and <4.0% time in hypoglycemia (<3.9 mmol/L) | 5 (21.7) | 7.5–43.7 |
| HbA1c <7.0% and <1.0% time in hypoglycemia (<3.0 mmol/L) | 1 (25.0) | 0.6–80.6 |
| HbA1c <7.0% and <4.0% time in hypoglycemia (<3.9 mmol/L) | 1 (25.0) | 0.6–80.6 |
| End of CGM treatment | ||
| HbA1c <7.5% and <1.0% time in hypoglycemia (<3.0 mmol/L) | 24 (57.1) | 41.0–72.3 |
| HbA1c <7.5% and <4.0% time in hypoglycemia (<3.9 mmol/L) | 23 (54.8) | 38.7–70.2 |
| HbA1c <7.0% and <1.0% time in hypoglycemia (<3.0 mmol/L) | 3 (27.3) | 6.0–61.0 |
| HbA1c <7.0% and <4.0% time in hypoglycemia (<3.9 mmol/L) | 3 (27.3) | 6.0–61.0 |